Clinical Trial Update: Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress [Phase 2]

View source ↗

Summary

This completed Phase 2 trial assesses whether insulin resistance–reducing agents given before and after coronary artery bypass grafting improve postoperative me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Insulin resistance reducing agents

Snippet

Sponsor: Mohammad Hassan Eftekhari | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED